Home
Kiadis Pharma N.V.

Kiadis Pharma N.V. Market Share Analysis for May 2026

we provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people

Health > Biotechnology and Pharmaceuticals

Domainkiadis.com

Year Founded1997

Employees51 - 200

Annual Revenue$25M - $50M

Kiadis Pharma N.V.

Kiadis Pharma N.V. (including company regionals)

kiadis.com

See more website traffic and engagement information

Kiadis Pharma N.V. Revenue up to May 2026 is 25M - 50M

revenue generated by Kiadis Pharma N.V. top domains

Kiadis Pharma N.V. top domains revenue over 3 years

Revenue for Kiadis Pharma N.V. top domains

kiadis.com25M - 50M

See more with Sales Intelligence

Total visits to Kiadis Pharma N.V.'s top domains

Understand Kiadis Pharma N.V. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Kiadis Pharma N.V.'s top domains

Analyze Kiadis Pharma N.V. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Kiadis Pharma N.V.'s top domains

See how Kiadis Pharma N.V. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Kiadis Pharma N.V. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

san-bio.comCompany NameSanBio, Inc.Employees51 - 200HQUnited States, California, Mountain ViewAnnual revenue< $1MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Kiadis Pharma N.V.

These are the website technologies, by industry, used by Kiadis Pharma N.V. top domains

Widget (6)

Twemoji

Audio Video Media (2)

YouTube

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Kiadis Pharma N.V.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSanofi acquired Kiadis for $305M on Jan 1st '20.Sanofi inked a deal with Scribe Therapeutics in September and acquired Kiadis Pharma and its allogeneic NK cell technology platform in 2020.

NewsSandler leaves Kiadis as Chief Medical Officer.Dr. Sandler joins Alpine from Kiadis Pharma, a Sanofi Company, where he was Chief Medical Officer.

NewsMarcel Zwaal leaves Kiadis as CEO.Over the last few months this transition has been led by CEO Marcel Zwaal who joined from Kiadis Pharma, the Dutch NK cell therapeutics company acquired by Sanofi for $358 million.